BAX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the expense the company spent on research and development. Baxter International Inc.'s research and development for the three months ended in Dec. 2013 was $437 Mil. Its research and development for the trailing twelve months (TTM) ended in Dec. 2013 was $1,246 Mil.
This is the expense the company spent on research and development.
Baxter International Inc. Research & Development for the trailing twelve months (TTM) ended in Dec. 2013 was 246 (Mar. 2013 ) + 273 (Jun. 2013 ) + 290 (Sep. 2013 ) + 437 (Dec. 2013 ) = $1,246 Mil.
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
Baxter International Inc. Annual Data
|Research & Development||517||533||614||760||868||917||915||946||1,156||1,246|
Baxter International Inc. Quarterly Data
|Research & Development||239||254||269||306||290||291||246||273||290||437|